Travere Therapeutics, Inc.

TVTX· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$62.76-3.06%

2026-09-18

Financials

Valuation Metrics

Travere Therapeutics, Inc.'s Market Cap is $5.84B. At end of 2025 it was $3.45B. Ranked #1225 of 3,121 in US market (top 39%), #410 of 1,463 on NASDAQ (top 28%), #69 of 266 in Pharmaceuticals, Biotechnology & Life Sciences (top 26%) by Market Cap.

Investment Metrics(as of 2026-09-18)

Metric	Value	Rank
Size
Market Cap	$5.84B	US#1,225/3,121 Sec#69/266
Revenue	$591M	US#2,186/3,121 Sec#72/266
Net Income	$-43M	US—/3,121 Sec—/266
Total Assets	$799M	US#2,573/3,121 Sec#119/266
Net Assets	$25M	US#2,895/3,121 Sec#234/266
Value
P/B	238.00x	US#2,918/3,121 Sec#241/266
P/S	9.87x	US#2,693/3,121 Sec#112/266
EV/EBITDA	4103.24x	US#2,524/3,121 Sec#87/266
FCF Yield	0.88%	US#2,202/3,121 Sec#79/266
Profitability
ROE	-177.24%	US#2,838/3,121 Sec#215/266
ROA	-5.44%	US#2,544/3,121 Sec#89/266
Op. Margin	-6.84%	US#2,508/3,121 Sec#88/266
Revenue Growth	77.12%	US#137/3,121 Sec#38/266
Financial Health
Debt Ratio	3159.77%	US#2,890/3,121 Sec#239/266
Total Debt	$617M	US#1,773/3,121 Sec#59/266
FCF	$52M	US#1,981/3,121 Sec#70/266
Cash	$118M	US#2,115/3,121 Sec#161/266
Current Ratio	4.05x	US#575/3,121 Sec#165/266
Performance
1Y Return	159.45%	US#83/3,121 Sec#31/266
1M Return	-4.85%	US#802/3,121 Sec#81/266
From 52W High	-8.69%	US#371/3,121 Sec#27/266
1Y MDD	-33.49%	US#1,661/3,121 Sec#109/266
Trading
Volume	1,971,029 shares	US#1,155/3,121 Sec#116/266
Trading Value	$125M	US#925/3,121 Sec#64/266
Per Share
EPS	$-0.47	US—/3,121 Sec—/266
BPS	$0.26	US#2,788/3,121 Sec#227/266